NASDAQ:BTMD
biote Corp. Stock News
$7.65
+0.250 (+3.38%)
At Close: Jul 02, 2024
biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?
04:30am, Monday, 24'th Jun 2024
biote Corp. (BTMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares
04:45pm, Thursday, 20'th Jun 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
biote Corp. (BTMD) Q1 2024 Earnings Call Transcript
03:58am, Thursday, 09'th May 2024
biote Corp. (NASDAQ:BTMD ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Simon Serowiecki - Investor Relations Terry Weber - Chief Executive Officer Bob Peterson - Chief
Biote Corp. (BTMD) Q1 Earnings Beat Estimates
07:50pm, Tuesday, 07'th May 2024
Biote Corp. (BTMD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.94 per share a year ago.
Biote Reports First Quarter 2024 Financial Results
04:05pm, Tuesday, 07'th May 2024
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a
Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline
11:06am, Tuesday, 30'th Apr 2024
Biote Corp. (BTMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biote Announces Definitive Settlement with Founder
04:05pm, Monday, 29'th Apr 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
04:05pm, Tuesday, 23'rd Apr 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
This overlooked corner of women's health could be a $350 billion market opportunity
02:33pm, Friday, 15'th Mar 2024
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
biote Corp. (BTMD) Q4 2023 Earnings Call Transcript
07:45pm, Tuesday, 12'th Mar 2024
biote Corp. (BTMD) Q4 2023 Earnings Call Transcript
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Tuesday, 12'th Mar 2024
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a
Analysts Estimate biote Corp. (BTMD) to Report a Decline in Earnings: What to Look Out for
11:01am, Tuesday, 05'th Mar 2024
Biote Corp. (BTMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biote Announces $20 Million Share Repurchase Authorization
04:05pm, Thursday, 25'th Jan 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
Biote to Purchase Asteria Health
04:05pm, Wednesday, 17'th Jan 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
04:05pm, Wednesday, 17'th Jan 2024
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optim
